Table 3 Medication after one year
No CKD | CKD Stage 1 | CKD Stage 2 | CKD Stage 3 | CKD Stage 4 | CKD Stage 5 | CKD Stage 5D | p value | |
|---|---|---|---|---|---|---|---|---|
Oral anticoagulant, % (95%CI) | 12.5 (12.3–12.7) | 18.4 (16.3–20.6) | 21.2 (20.2–22.1) | 25.7 (25.0–26.3) | 25.0 (23.5–26.5) | 21.7 (18.9–24.6) | 17.7 (14.8–20.8) | < 0.001 |
Platelet inhibitor, % (95%CI) | 95.9 (95.8–96.0) | 94.4 (93.6–94.7) | 94.2 (93.6–94.7) | 91.8 (91.4–92.3) | 88.6 (87.5–89.7) | 90.5 (88.3–92.3) | 94.9 (92.8–96.4) | < 0.001 |
Oral anticoagulant and/or platelet inhibitor, % (95%CI) | 96.6 (96.5–96.7) | 95.1 (94.7–95.7) | 95.2 (94.7–95.7) | 92.7 (92.3–93.1) | 88.7 (87.6–89.8) | 89.6 (87.3–91.5) | 92.1 (89.6–94.0) | < 0.001 |
Statin, % (95%CI) | 93.7 (93.5–93.8) | 90.0 (88.2–91.6) | 90.7 (90.0–91.3) | 85.1 (84.6–85.7) | 78.2 (76.7–79.6) | 77.6 (74.5–80.3) | 75.2 (71.6–78.4) | < 0.001 |
Beta-blocker, % (95%CI) | 93.2 (93.1–93.4) | 93.3 (91.7–94.6) | 93.6 (93.0–94.1) | 92.3 (91.9–92.7) | 90.4 (89.3–91.3) | 90.1 (87.9–92.0) | 90.9 (88.4–92.9) | < 0.001 |
ACE inhibitor or ARB, % (95%CI) | 93.1 (93.0–93.3) | 94.3 (92.8–95.5) | 94.1 (93.6–94.7) | 93.0 (92.6–93.4) | 89.6 (88.5–90.6) | 82.2 (79.4–84.7) | 76.7 (73.1–79.9) | < 0.001 |
All four drug groups*, % (95%CI) | 83.4 (83.2–83.7) | 79.3 (76.9–81.5) | 81.5 (80.6–82.4) | 74.7 (74.0–75.4) | 65.0 (63.3–66.7) | 59.4 (55.9–62.7) | 53.7 (49.7–57.6) | < 0.001 |